Equinox Pharma Holding Ltd. acquired additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (CASE:RMDA) for EGP 58.3 million on July 29, 2021. Under the term, Equinox will acquire 20.83 million shares of Rameda for EGP 2.8 per share. Post completion, Equinox its stake in Rameda from 12.68% to 15.39%. Equinox Pharma Holding Ltd. completed the acquisition of additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (CASE:RMDA) on July 29, 2021.